| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2006-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88457d01cbcb909422487a5e51acdd57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c2957fd5515aec2a16365d52f033f7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4dd4e47b52aeb55057a0faef83c4da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e88766aaf3b7dcb9b17ff0ee0dcb3f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba450f3a20071d514bc6d1eff4be0eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd5bba3149f62377fcc2183290d3be4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d23bbfa51bb7629128c8cca88e878d |
| publicationDate |
2008-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1928856-A1 |
| titleOfInvention |
Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| abstract |
The present invention relates to novel quinoline derivatives such as compounds of the formula (I) which possess antagonist potency for the 5-HT6 receptor and/or are capable of selectively modulating the cannabinoid 2 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of CNS disorders. |
| priorityDate |
2005-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |